Your Article Summary
(Click the title below to leave the MDLinx Network and go to the Journal's Website)
ORENCIA (abatacept) Demonstrates Consistent Safety and Effectiveness Over 7 Years
Bristol Myers-Squibb Company, 06/18/09
The first, a long-term extension study, analysed ORENCIA's safety and efficacy profile over 7 years of treatment in rheumatoid arthritis patients who have had an inadequate response to methotrexate.
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves New Test to Aid in the Diagnosis of Rheumatoid Arthritis
Abbott, 10/21/09
Myriad Genetics Acquires Exclusive Rights to Pancreatic Cancer Gene Patents From Johns Hopkins
Myriad, 10/16/09
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Article Search
Sponsor


See Latest Articles


